AbbVie Inc. (NYSE:ABBV) closed its last session at $64.16 with the change of +1.15%. The market capitalization of the company is $103.77B with an average Volume of 8.81 million shares. The stock currently has its 52-Week High range of $71.60 and 52-week low range of $45.45. The Price to Book (P/B) ratio stands at 22.09. The stock traded total quantity of 7.92 million shares.
For the current Fiscal Quarter, 17 analysts have given an average earnings per share forecast of $1.2. The Low Earnings per share estimate of the current Quarter is $1.16 and High Estimate is set at $1.27 according to these Analysts opinions. The Previous Year EPS of this Quarter is $1.08.
According to 14 analysts, an average sales Estimate of the current Fiscal quarter is $6.20B. The lower sales estimate is $6.07B and higher sales estimate is $6.45B according to these Analysts thoughts.
The Company currently has Highest Price Target of $90 and Lowest Price Target of $47. It has Median Price Targets of $69. Mean price target is set at $70 after consensus analysis of 18 brokers.
When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month 4 analysts have assigned this stock as Strong Buy where 7 assigned Buy, 8 analysts believe it’s a Hold, 1 said Underperform and 0 assigned Sell rating.
DENTSPLY International Inc. (NASDAQ:XRAY) ended its last trade at $63.39 with the move of +1.42%. The company has market value of $14.85B with the total traded volume of 1.43 million. The stock currently has its 52-Week top value of $65.83 and 52-week down value of $49.48. The price to book (P/B) ratio of the company is 1.75. Its previous closing price was recorded at $62.50.
For the current Fiscal Quarter, 12 analysts have given an Average earnings estimate of $0.7 per share. According to the Analysts, the Low Estimate Earnings of the current Quarter is $0.68 while High Estimate is $0.72. The Previous Year EPS of this Quarter is $0.73.
According to 11 analysts, an Average Revenue Estimate of the current Fiscal quarter is $1.03B. According to them, the Low Revenue estimate is $998.10M and High Revenue estimate is $1.05B.
The Company currently has High Price Target of $78. The Low and Mean Price Targets are $63 and $68.67 respectively. These price targets are set after consensus analysis of 9 brokers.
When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month, 4 analysts have given this stock as Strong Buy where 2 issued Buy, 7 analysts think that it’s a Hold, 0 told Underperform and0 assigned Sell rating.